Skip to content

Research on prevention of oral mucositis using sesame oil

Study on the preventive effect of sesame oil on the onset of oral mucositis during high-dose methotrexate therapy for central nervous system lymphoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1030230334
Enrollment
50
Registered
2023-09-07
Start date
2023-09-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central nervous system lymphoma

Interventions

In HD-MTX therapy, the standard care for oral mucositis is brushing with a toothbrush and gargling with allopurinol gargling water. Therefore, we will compare two groups: a group gargles with allopuri

Sponsors

TADERA Noriyuki
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Persons aged 20 years or older who can write informed consent before starting treatment 2. Those receiving first-time HD-MTX therapy 3. Persons who are orally ingesting regular food (not soft vegetarian food, swallowing food, etc.) 4. Those with good oral conditions 5. Persons who are able to perform oral care on their own

Exclusion criteria

Exclusion criteria: 1. Those with a history of long-term use of steroids, immunodeficiency, or diabetes 2. Those suffering from an infectious disease 3. Persons who are currently being treated for cancer in another location (if they have received treatment for cancer in another location in the past, those who have completed surgery, drug therapy, or radiation therapy for less than 2 years) 4. Persons who are allergic to sesame oil

Design outcomes

Primary

MeasureTime frame
The severity of oral mucositis using CTCAE v5.0

Secondary

MeasureTime frame
1. Inflammatory changes by oral mucosal cytology 2. Dry mouth, dysphagia, pain, taste changes, anorexia, and nausea using PRO-CTCAE as subjective evaluations by research subjects

Contacts

Public ContactKenji KATSURAGI

Kitasato University

k.katsu@nrs.kitasato-u.ac.jp+81-42-778-9382

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026